Yuhan Corporation operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Yuhan with three other
pharmaceutical manufacturers in Asia:
Green Cross Holdings Corporation
sales of 1.13 trillion Korean Won [US$1.00 billion]
Kissei Pharmaceutical Company Limited
(70.11 billion Japanese Yen [US$672.35 million]
of which 85%
was Pharmaceutical Products), and
China Resources Double-Crane Pharmaceutical Company Limited
based in China
(5.14 billion Chinese Renmimbi [US$757.47 million]
of which 52%
Yuhan reported sales of 1.13 trillion Korean Won (US$998.93 million)
December of 2015.
increase of 10.9%
versus 2014, when the company's sales were 1.02 trillion Korean Won.
Sales at Yuhan have increased during each of the previous five years
(and since 2010, sales have increased a total of 70%).